New trial alert: Prostate accurately targeted radiation therapy investigation of overall treatment time

The purpose of this study is to compare the toxicity of two new radiation schedules for the treatment of prostate cancer. Patients will be randomized to receive 5 treatments delivered every other day over 11 days, or once per week over 29 days. Both of these schedules are shorter than the standard treatment which is usually 39 treatments over 8 weeks.

Trial start Date: January, 2012
Principal Investigator(s):
Andrew Loblaw, MD , Sunnybrook Health Sciences Centre
Harvey Quon, MD , CancerCare Manitoba

See more details here.